Apimeds Pharmaceuticals Us, Inc.
APUS
Revenue
0.00
0.000.00%
-Assets
9.25M
▼-1.30M▼-12.29%
3 Months ChangeLiabilities
1.09M
▲280.38k▲34.66%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-02
Form 8-K
ID: 0001213900-26-000464
2025-12-10
Form 8-K
ID: 0001213900-25-119894
2025-12-02
Form 8-K
ID: 0001213900-25-117173
2025-11-18
Form 8-K
ID: 0001213900-25-112184
2025-11-12
Form 10-Q
ID: 0001213900-25-109280
2025-10-16
Form 8-K
ID: 0001213900-25-099553
2025-08-19
Form 10-Q
ID: 0001213900-25-078507
2025-07-16
Form 8-K
ID: 0001213900-25-064446
2025-06-05
Form 8-K
ID: 0001213900-25-051567
2025-05-20
Form 8-K
ID: 0001213900-25-045643